These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27101805)

  • 21. A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction.
    Govier F; Potempa AJ; Kaufman J; Denne J; Kovalenko P; Ahuja S
    Clin Ther; 2003 Nov; 25(11):2709-23. PubMed ID: 14693299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating women's preference for sildenafil or tadalafil use by their partners with erectile dysfunction: the partners' preference study.
    Conaglen HM; Conaglen JV
    J Sex Med; 2008 May; 5(5):1198-1207. PubMed ID: 18312284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk-benefit assessment of oral phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction: a multiple criteria decision analysis.
    Hsu JC; Tang DH; Lu CY
    Int J Clin Pract; 2015 Apr; 69(4):436-43. PubMed ID: 25311239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the long-term safety and effectiveness of tadalafil once daily in Chinese men with erectile dysfunction: interim results of a multicenter, randomized, open-label trial.
    Jiang H; Zhao LM; Lin HC; Yan S; Liu JH; Zhu ZH; Luo JD; Dai YT; Li FB; Lou Y; Zhang ZC
    Asian J Androl; 2018; 20(6):587-592. PubMed ID: 30004039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparisons of regular and on-demand regimen of PED5-Is in the treatment of ED after nerve-sparing radical prostatectomy for Prostate Cancer.
    Qiu S; Tang Z; Deng L; Liu L; Han P; Yang L; Wei Q
    Sci Rep; 2016 Sep; 6():32853. PubMed ID: 27611008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy.
    Kim ED; Seftel AD; Goldfischer ER; Ni X; Burns PR
    J Sex Med; 2014 Mar; 11(3):820-30. PubMed ID: 23841532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The treatment of erectile dysfunction study: focus on treatment satisfaction of patients and partners.
    Brock G; Chan J; Carrier S; Chan M; Salgado L; Klein AH; Lang C; Horner R; Gutkin S; Dickson R
    BJU Int; 2007 Feb; 99(2):376-82. PubMed ID: 17155989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Safety of Sildenafil in Men With Sexual Dysfunction and Spinal Cord Injury.
    Ohl DA; Carlsson M; Stecher VJ; Rippon GA
    Sex Med Rev; 2017 Oct; 5(4):521-528. PubMed ID: 28341580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment satisfaction of men and partners following switch from on-demand phosphodiesterase type 5 inhibitor therapy to tadalafil 5 mg once daily.
    Burns PR; Rosen RC; Dunn M; Baygani SK; Perelman MA
    J Sex Med; 2015 Mar; 12(3):720-7. PubMed ID: 25615445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse reactions of PDE5 inhibitors: An analysis of the World Health Organization pharmacovigilance database.
    Lui JL; Shaw NM; Abbasi B; Hakam N; Breyer BN
    Andrology; 2023 Oct; 11(7):1408-1417. PubMed ID: 36905319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychosocial impact and effectiveness of tadalafil among treatment-naïve and previously-treated men with erectile dysfunction in Saudi Arabia and other Gulf-region countries.
    El Khiat Y; Ghazi S; Allam A; Khawaja M; Belger M; Tamer M; Kopernicky V
    Curr Med Res Opin; 2008 Jul; 24(7):1965-73. PubMed ID: 18547465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of Combination Therapies vs Monotherapy for Erectile Dysfunction: A Systematic Review and Meta-analysis.
    Mykoniatis I; Pyrgidis N; Sokolakis I; Ouranidis A; Sountoulides P; Haidich AB; van Renterghem K; Hatzichristodoulou G; Hatzichristou D
    JAMA Netw Open; 2021 Feb; 4(2):e2036337. PubMed ID: 33599772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the association between erectile rigidity and treatment adherence with sildenafil.
    Mazzola CR; Deveci S; Teloken P; Mulhall JP
    J Sex Med; 2013 Jul; 10(7):1861-6. PubMed ID: 23253943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction: Pharmacology and Clinical Impact of the Sildenafil Citrate Orodispersible Tablet Formulation.
    Scaglione F; Donde S; Hassan TA; Jannini EA
    Clin Ther; 2017 Feb; 39(2):370-377. PubMed ID: 28139291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment preferences of patients with erectile dysfunction: a systematic review of randomized controlled trials.
    Manfredi C; Franco A; Ditonno F; Mathur R; Franco G; Lombardo R; Russo GI; DE Cillis S; Fiori C; Arcaniolo D; Antonelli A; Autorino R; DE Sio M; DE Nunzio C
    Minerva Urol Nephrol; 2024 Feb; 76(1):42-51. PubMed ID: 38426421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Continuous Dosing of Tadalafil Once Daily vs Tadalafil On Demand in Clinical Subgroups of Men With Erectile Dysfunction: A Descriptive Comparison Using the Integrated Tadalafil Databases.
    Brock G; Ni X; Oelke M; Mulhall J; Rosenberg M; Seftel A; D'Souza D; Barry J
    J Sex Med; 2016 May; 13(5):860-75. PubMed ID: 27114197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
    Skoumal R; Chen J; Kula K; Breza J; Calomfirescu N; Basson BR; Kopernicky V
    Eur Urol; 2004 Sep; 46(3):362-9; discussion 369. PubMed ID: 15306109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of once-daily tadalafil on confidence and perceived difficulty in performing sexual intercourse in men who were incomplete responders to as-needed PDE5 inhibitor treatment.
    Seftel AD; Rosen RC; Hayes RP; Althof S; Goldfisher E; Shen W; Sontag A
    Int J Clin Pract; 2014 Jul; 68(7):841-9. PubMed ID: 24666765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Timing of dose relative to sexual intercourse attempt in previous sildenafil citrate users treated with tadalafil.
    Glina S; Sotomayor M; Gatchalian E; Yaman O; Dyachkova Y; Markey C; Kopernicky V
    J Sex Med; 2006 Mar; 3(2):309-19. PubMed ID: 16490025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.